Lipoprotein Marker for Hypertriglyceridemia.
Patent, Filed 10 May 84, patented 28 Oct 86,
DEPARTMENT OF THE NAVY WASHINGTON DC
Pagination or Media Count:
Methods and compositions are provided for the detection of a particular low density lipoprotein which has been found to be a marker for patients suffering from type IV hypertriglyceridemia. A monoclonal antibody capable of specifically binding to a characteristic epitopic site on this LDL subspecies can be utilized in a wide variety of immunoassays.
- Medicine and Medical Research